TC
AMGN icon

Trilogy Capital’s Amgen AMGN Stock Holding History

Trilogy Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$302K Sell
833
-9,302
-92% -$3.18M 0.01% 331
2026
Q1 		$3.57M Sell
10,135
-255
-2% -$90.9K 0.16% 103
2025
Q4 		$3.4M Buy
10,390
+96
+0.9% +$30.5K 0.15% 114
2025
Q3 		$2.9M Sell
10,294
-423
-4% -$123K 0.13% 114
2025
Q2 		$2.99M Sell
10,717
-285
-3% -$80.7K 0.15% 104
2025
Q1 		$3.43M Buy
11,002
+74
+0.7% +$21.9K 0.18% 79
2024
Q4 		$2.85M Buy
10,928
+886
+9% +$263K 0.15% 110
2024
Q3 		$3.24M Sell
10,042
-207
-2% -$67.7K 0.16% 100
2024
Q2 		$3.2M Buy
10,249
+329
+3% +$96.7K 0.17% 92
2024
Q1 		$2.82M Buy
9,920
+360
+4% +$105K 0.16% 110
2023
Q4 		$2.75M Sell
9,560
-665
-7% -$181K 0.17% 99
2023
Q3 		$2.75M Buy
+10,225
New +$2.55M 0.19% 76
2022
Q1 		– Sell
-1,365
Closed -$307K – 168
2021
Q4 		$307K Sell
1,365
-110
-7% -$23.2K 0.02% 142
2021
Q3 		$314K Buy
1,475
+1
+0.1% +$230 0.02% 131
2021
Q2 		$360K Buy
+1,474
New +$363K 0.03% 130
2020
Q1 		– Sell
-1,305
Closed -$311K – 103
2019
Q4 		$311K Hold
1,305
– – 0.03% 102
2019
Q3 		$255K Buy
1,305
+1
+0.1% +$192 0.03% 104
2019
Q2 		$238K Sell
1,304
-140
-10% -$25.1K 0.03% 106
2019
Q1 		$274K Sell
1,444
-101
-7% -$19.3K 0.03% 103
2018
Q4 		$301K Buy
1,545
+201
+15% +$39.2K 0.04% 107
2018
Q3 		$279K Buy
1,344
+47
+4% +$9.26K 0.03% 117
2018
Q2 		$239K Buy
1,297
+151
+13% +$26.7K 0.03% 112
2018
Q1 		$195K Buy
+1,146
New +$210K 0.03% 115

Other funds holding AMGN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Trilogy Capital's AMGN Position: Q2 2026 in Review

Trilogy Capital reduced its Amgen (AMGN) stake by 92% in Q2 2026, selling an estimated $3.18M and leaving 833 shares worth $302K. The position accounts for 0.01% of the portfolio, ranked #331.

Trilogy Capital first reported a position in AMGN in Q1 2018 and has held it in 23 quarters since. The position peaked at $3.57M in Q1 2026. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Trilogy Capital held 833 shares of Amgen worth $302K as of Q2 2026.
  • Trilogy Capital sold 9,302 Amgen shares in Q2 2026, an estimated $3.18M.
  • Amgen made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #331 holding.
  • Trilogy Capital first reported a position in Amgen in Q1 2018 and has held it in 23 quarters since.
  • Trilogy Capital's Amgen position peaked at $3.57M in Q1 2026.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.